Time away from the lab is limited and valuable. You need to return from SLAS in San Diego with new tools to raise your scientific research… your “Out of the Office ROI.”
Drug discovery is always evolving. From new processes to advanced technologies, excellence in drug discovery is the result of combining different approaches. And each approach brings a specific answer.
We sat down with expert Chris Strom, former service procurement manager at Bristol-Myers Squibb, to gain some insights into understanding successful vendor relationships and how to decide which procurement model fits your lab.
It’s not always easy to figure out whether your software is 21 CFR Part 11 compliant or compatible. Regulations for 21 CFR Part 11 state that electronic records, electronic signatures, and handwritten signatures converted into digital copies are all trustworthy, reliable, and equal to handwritten signatures on paper.
A lab disaster can come in the form of a fire, tornado, loss of electricity, cyber attack, compromised assay components, or more. With profitability and results on the line, many pharma labs are taking steps to develop disaster prevention strategies as well as carefully thought-out response plans.
When most of us encounter bacteria, we reach for a sanitizer. Researchers at the Cork Cancer Research Centre in Cork, Ireland, have a much different reaction. They view these single-cell microorganisms as literal torchbearers in advancing new therapies for infectious diseases especially as it relates to cancer.
Hybrid approaches to lab management are now becoming the norm, globally, with the lure and benefit of promising a more efficient, optimal operation within labs – including reducing undue burden on lab managers.
Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe.
A group of scientists at the Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed a new microscopy technique for blood cells that saves time, money, and, most importantly, is already helping to uncover new immunotherapy treatments for cancer.
The nanotech world just witnessed a revolution. For the first time in history, scientists at the University of South Carolina’s Center for Environmental NanoScience and Risk (CENR) and PerkinElmer have precisely quantified the uptake of metal nanoparticles by individual cells.